Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy.

J Clin Med · 2021 · PMC8347271 · PMID 34362163

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The body weight, BMI, hs-CRP, and HbA1c were significantly decreased among the treated patients in the first 12 weeks, while these variables showed an increasing trend throughout the therapy duration in the control group ( Figure 2 A,B,D,H).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.